Systane Clinical Experience Study

Alcon Research941 enrolled

Overview

To evaluate the physical effect of SYSTANE QID in people that have moderate to severe dry eyes and to establish doctor confidence to prescribe Systane.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

941

Conditions

Dry Eye Syndrome

Interventions

SystaneOTHER

Systane prescription

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * moderate to severe dry feeling eyes Exclusion Criteria: * None

Outcomes

Primary Outcomes

corneal and conjunctiva staining score

Time frame: 4 weeks

Secondary Outcomes

Tear film break up time

Time frame: 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.